The major histocompatibility complex-encoded gene, Hfe, has been implicated to play a pivotal role in hereditary hemochromatosis, a common autosomal recessive disorder of iron metabolism. The recent finding that a physical interaction between HFE and transferrin receptor establishes a functional link between HFE and transferrin receptormediated iron metabolism in the pathophysiology of hereditary hemochromatosis. To elucidate the underlying mechanisms by which HFE interacts with and affects transferrin receptor function, we have systematically investigated the consequences of the HFE-transferrin receptor interaction in cellular iron homeostasis. Herein we show that in HFEexpressing cells, the amount of intracellular transferrin is decreased by ෂ28%, despite a ෂ40% increase in surfaceexpressed transferrin receptor. Kinetic analysis of receptor-bound transferrin endocytosis reveals that HFE expression not only reduces transferrin binding but also abrogates transferrin receptor endocytosis. As a result, HFE expression leads to an accumulation of non-functional transferrin receptors at the cell surface, and a decrease in iron uptak. Moreover, HFE expression induces hyper-serine phosphorylation of the transferrin receptor. Taken together, these results suggest that HFE negatively modulates cellular iron uptake by impairing transferrin receptor endocytosis via HFE-induced receptor phosphorylation. Genes and Immunity (2000) 1, 409-417.
Introduction
Hereditary hemochromatosis is a common autosomal recessive disorder of iron metabolism characterized by progressive iron overload. 1 The gene that causes hereditary hemochromatosis has been identified as a non-classical class I gene, Hfe, 2, 3 encoded in the major histocompatibility complex (MHC). Non-classical class I molecules are traditionally perceived as more ancient than their classical counterparts and believed to be involved in first line of defense against pathogens. 4 Accordingly, nonclassical class I molecules, including HFE, are found to be primarily located in the barrier tissues such as the gut mucosa, placenta, and lung. Even though a direct role for HFE in the immune response against pathogens remains to be investigated, several lines of evidences suggest a functional link between iron homeostasis and immune function. 5 A recent demonstration of the association between HFE molecule and transferrin receptor (TfR) provides critical insights into the roles of HFE in iron homeostasis. [6] [7] [8] [9] Because the levels of TfR expression are functionally linked to the requirements of the cells for iron, TfR plays an essential role in cellular iron metabolism. [10] [11] [12] [13] 8 May 2000 ment and an abnormal iron homeostasis.
14 Upon binding to the diferric transferrin (Tf), TfR-Tf is endocytosed into endosomes, where the low pH causes Tf to release its iron into the cytosol. The TfR-bound Tf recycles to the cell surface, where the Tf rapidly dissociates at neutral pH. 11 It has been reported that by associating with TfR, HFE appears to be able to reduce the affinity of TfR for its ligand. 9, 15 However, it is important to note that TfR-Tf complexes undergo rapid recycling and that the concentration of diferric Tf in blood is ෂ5 m, a value that greatly exceeds the K D of Tf for TfR. 11 In this regard, it is unlikely that the effects of HFE on TfR function are simply attributed to a reduction of Tf affinity.
We have recently demonstrated that HFE interferes with TfR endocytosis, 6 which is mediated by a conserved tyrosine-based internalization signal located in the Nterminal cytoplasmic domain of the receptor. 16, 17 This internalization domain appears to interact directly with one or more adaptor proteins that may recruit TfR complexes into clathrin-coated pits. 11 Deletion and other mutational analyses indicate that besides the internalization signal, other residues within the internalization domain can also affect TfR endocytosis. The finding that HFE remains complexed with TfR on the cell surface raises the question of whether HFE binding induces conformational changes and/or post-translational modification in the receptor. [18] [19] [20] The present study shows that HFE binding abrogates endocytosis of TfR-Tf, resulting in a decrease in the uptake of intracellular Tf-bound iron.
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Furthermore, evidences presented here suggest that HFEinduced conformational changes in TfR promote hyperserine phosphorylation of the receptor, which in turn interferes with endocytosis of the receptor.
Results

Effect of HFE on TfR expression and cell proliferation
To study the effects of HFE binding on TfR function, we generated stable HeLa transfectants in which the levels of Hfe gene expression are inversely proportional to the amounts of tetracycline used in the medium. 21 One of the transfectants, named LS15, was selected for further characterization. In the presence of tetracycline, LS15 cells expressed an equivalent amount of surfaceexpressed TfR to that of the parental HeLa cells (not shown), suggesting that tetracycline has no effect on TfR expression. Flow cytometric analysis showed that after removal of the tetracycline, LS15 cells expressed high levels of HFE on the cell surface ( Figure 1a , left panel). Because HFE expression was not detected in LS15 cells in the presence of tetracycline, expression of HFE in LS15 cells must be tightly regulated by tetracycline. When these cells were allowed to grow in the absence of tetracycline for 2 days, the surface expression levels of TfR increased substantially, compared to the HFE-negative control cells ( Figure 1a , right panel; Table 1 ). These results suggest that HFE expression and binding to TfR results in an accumulation of TfR at the cell surface. As shown in Figure 1b , the growth rate for LS15 cells cultured in the presence or absence of tetracycline was almost identical for the first 3 days, indicating that HFE expression does not interfere with cellular function for this time period. However, the growth rate of LS15 cells decreased 3 days after HFE induction, while LS15 cells cultured in the presence of tetracycline grew exponentially. Since TfR function is required for cell proliferation, these observations suggest that HFE expression progressively leads to a complete inhibition of TfR function, which results in cell growth arrest.
Interaction and intracellular transport of HFE and TfR
To characterize the specific HFE-TfR interaction in LS15 cells, we used an antiserum against the C-terminal peptide of HFE (HFE-C) and a panel of monoclonal antibodies (mAb) against the HFE protein, as indicated in Figure 2 . To examine whether HFE binding affects the rates of intracellular transport of TfR, we performed pulse-chase experiments followed by immunoprecipitations using anti-HFE antibodies. As shown in Figure 2 , there were two isoforms of HFE proteins: the one (HFE L ) migrated with a faster electrophoretic mobility is endoglycosidase H (Endo H)-sensitive, whereas the other (HFE H ) with a slower electrophoretic mobility is Endo Hresistant. 6 Similarly, TfR displayed two isoforms, which can be distinguished by their sensitivities to Endo H digestion as well as their electrophoretic mobilities. The Endo H-sensitive forms of HFE and TfR (lanes 1, 4, 7, 10) were eventually converted to the Endo H-resistant forms (lanes 3, 6, 9, 12), indicating their precursor-product relationships. All four anti-HFE mAbs co-immunoprecipitated with both Endo H-sensitive and Endo H-resistant TfR in association with HFE, suggesting that TfR first associates with HFE in the endoplasmic reticulum. Although the mAbs of 8B6, 9G11, and 34B4 immunoprecipitated a greater amount of Endo H-sensitive HFE than 10G4 at the pulse time point (compare lane 7 to lanes 1, 4, and 10 of Figure 2 ), an equivalent amount of TfR was co-immunoprecipitated with HFE at all chase time points , and 6 h (lanes 3, 6, 9, 12, and 15). Cell lysates were immunoprecipitated with 8B6 (lanes 1-3), 9G11 (lanes 4-6), 10G4 (lanes 7-9), 34B4 (lanes 10-12), and HFE-C (lanes [13] [14] [15] by all of the mAbs tested, including 10G4. Because the amounts of Endo H-resistant HFE recognized by the different mAbs were almost identical, it can be concluded that 10G4 does not recognize free Endo H-sensitive HFE heavy chains. Densitometric analysis revealed that during intracellular trafficking, the stoichiometric ratio between TfR and HFE remained constant at 2:1, suggesting that one HFE molecule is functionally able to affect one TfR homo-dimer.
When similar pulse-chase studies were conducted using anti-HFE-C antiserum, only Endo H-sensitive HFE L was recognized, while ␤ 2 m and TfR did not co-immunoprecipitate at any time point (lanes [13] [14] [15] , suggesting that the C-terminal tail of Endo H-resistant HFE H is not available for binding by anti-HFE-C antiserum. Our finding showed that ␤ 2 m did not co-immunoprecipitate with the non-TfR-associated, Endo H-sensitive HFE L forms, suggesting that the binding of ␤ 2 m to HFE is a prerequisite for an interaction between HFE and TfR. Because 10G4, which recognizes the denatured form of HFE, 6 did not recognize the subset of non-TfR-associated Endo Hsensitive HFE L molecules, TfR binding appeared to induce conformational changes in the HFE protein. As a result of the HFE-TfR association, the 10G4 epitope became exposed, while the HFE-C epitope was masked.
HFE-mediated accumulation of non-functional TfR at the cell surface
Since the primary function of surface-expressed TfR is to internalize Tf-bound iron, effect of HFE expression on TfR will result in a change in surface binding, endocytosis, and/or recycling of TfR-bound Tf. Thus, we investigated whether HFE expression has any affects on surface and intracellular Tf levels in HeLa cells by flow cytometry. Cell surface binding of FITC-labeled diferric Tf in HeLa cells expressing HFE was examined after an incubation at 4°C for 90 min, using a pre-determined saturating concentration of FITC-Tf. 6 Semi-quantitative differences were observed for surface-bound and intraGenes and Immunity cellular FITC-Tf, as well as for surface-expressed TfR between cells that expressed HFE and those that did not. As summarized in Table 1 , the surface level of Tf in HFEexpressing cells was reduced by ෂ15%, whereas the intracellular level of Tf was ෂ28% lower than in cells that did not express HFE, despite of the fact that HFE-expressing cells had ෂ40% more surface-expressed TfR. These findings suggest that HFE expression not only impairs intracellular TfR-dependent Tf uptake but also results in an accumulation of non-functional TfR at the cell surface.
Kinetic analysis of TfR-dependent Tf recycling
To examine the effects of HFE on the endocytosis of TfRbound Tf, we studied the kinetics of 125 I-Tf uptake in LS15 cells using the pulse-chase protocol described in Materials and methods. The amounts of radioactivity in the chase medium, acid washes, and NaOH digests that correspond to the fractions containing externalized Tf, surface-bound Tf, and internalized Tf, respectively, were determined and plotted as a percentage of total radioactivity recovered at each time point. As shown in Figure  3 , at the end of the 4°C pulse, the relative amount of surface-bound (acid-displaceable) 125 I-Tf in HFE-expressing cells was similar to that as in the cells without HFE expression. Within 5 min of the chase at 37°C, ෂ25% of 125 I-Tf remained sensitive to acid removal in LS15 cells without HFE expression, while ෂ50% remained on HFEexpressing cell surface, suggesting an inhibition of Tf uptake. After 10 min at 37°C, less than 10% of 125 I-Tf was detected on surface of LS15 cells without HFE expression, whereas in HFE-expressing cells, the value was still greater than 30%. These observations led us to conclude that while the externalization rate of Tf remained almost identical in cells expressing different levels of HFE, the internalization rate was substantially decreased in HFEexpressing cells. The finding that the fraction of cell-associated, acid-resistant Tf in cells expressing HFE was two times lower than in cells without HFE expression further supports the conclusion that HFE expression impairs TfR-dependent Tf endocytosis.
HFE-mediated reduction of cellular iron uptake
The ultimate function of the Tf-TfR complex is to deliver iron into the cell. The uptake of Tf-bound iron by cells and the accumulation of iron in cells reflect the internalization and externalization efficiency of the Tf-TfR complexes and provide conclusive evidence for the effect of HFE on Tf-TfR complex. Figure 4 shows that the uptake of Tf-bound 59 Fe was slower in cells expressing HFE, demonstrating that HFE expressing cells accumulate iron at ෂ50% the rate of the cells without HFE expression. Because the efficiency of TfR internalization in cells expressing HFE was only ෂ50%, the observed decrease in intracellular iron accumulation was most likely due to the reduced efficiency of Tf endocytosis affected by HFE expression.
HFE-induced hyper-serine phosphorylation of TfR
Upon association, HFE may change the post-translational state of TfR and thereby influence the normal function of TfR. TfR has a 64 amino-acid cytoplasmic domain which contains several potential phosphorylation sites. 20, [22] [23] [24] [25] [26] Thus, post-translational modifications of TfR within this domain might interfere with TfR endocytosis. To address this question, we combined pulse-chase labeling with two-dimensional gel electrophoresis and Western blot analysis. LS15 cells were metabolically labeled for 16 hours with 35 S-methionine followed by a 4-h chase. As shown in Figure 5a , two-dimensional gel electrophoresis of immunoprecipitated HFE and TfR (left and middle panels) revealed seven distinct HFE isoforms distinguishable by their charges. Some of these HFE protein isoforms were not present in the anti-TfR immunoprecipitate (compare the left panel to the middle panel of Figure 5a ). The observation that a subset of HFE isoforms was not associated with the TfR is in agreement with the finding that, as shown in Figure 2 , some of the HFE L isoforms residing in the endoplasmic reticulum were not associated with TfR. These results demonstrate that only a fraction of TfR was associated with HFE molecules, even in cells expressing high levels of HFE, and further suggest that additional intracellular factors might be required for the association of HFE with TfR. Surprisingly, two-dimensional SDS-PAGE analyses revealed for the first time that non-transfected HeLa cells constitutively expressed a low amount of HFE (Figure 5a , right panel). Furthermore, the charge differences in TfR isoforms between cells with and without HFE expression were evident. As revealed in the middle panel of Figure  5a , the TfR isoforms that did not co-precipitated with HFE by 10G4 displayed a trailing streak toward the basic end along the first NEPHGE dimension, which is consistent with the observation that HFE-associated TfR isoforms were more acidic (Figure 5a, left panel) . Because TfR contains several potential phosphorylation sites in its N-terminal internalization domain, a likely explanation for the observed acidic shift in the TfR isoelectric point is that HFE-induced phosphorylation results in an increase in the acidity of the TfR. Interestingly, two major species of proteins with molecular weights of ෂ180 kDa (Figure 5a , arrow heads) co-precipitated with TfR when anti-TfR antibodies were used (Figure 5a , middle and right panels), but they were barely detected in the anti-HFE immunoprecipitate (Figure 5a, left panel) . This suggests that HFE-associated TfR does not associate with these 180-kDa proteins. HFE might compete with TfRassociated factors for the same binding site on TfR, or sterically block their interactions with TfR. Alternatively, by inducing TfR conformational changes, HFE can interfere with the binding of these factors to TfR.
To examine whether HFE modulates the phosphorylation state of TfR, immunoprecipitates from 35 S-methionine labeled LS15 cells with and without HFE expression, were analyzed by SDS-PAGE and Western blotting.
Immunoprecipitated TfR with anti-TfR antibodies was
Genes and Immunity separated by SDS-PAGE, transferred to a nylon membrane, and probed with anti-phosphoserine (Figure 5b , S), -phosphothreonine (T), and -phosphotyrosine (Y) antibodies. The same membrane analyzed by Western blot was exposed to Kodak Biomax MS film to determine the total amount of 35 S-methionine labeled TfR present in the immunoprecipitates (Figure 5b, lower panel) . While the anti-phosphothreonine and anti-phosphotyrosine mAbs did not recognize any phosphorylated proteins, the antiphosphoserine antibodies specifically recognized TfR molecules of ෂ75 kDa in the anti-TfR immunoprecipitates (Figure 5b, S) . To determine the relative intensity of serine-phosphorylation expressed per TfR molecule, the intensity of serine-phosphorylated TfR was quantitated in cells with (Figure 5b , lanes 2 and 4) and without ( Figure 5b, lanes 1 and 3) HFE expression, and the values were normalized to the total amount of precipitated 35 Smethionine labeled TfR. It was found that in the presence of HFE, the intensity of phosphorylated TfR was at least two times higher than in cells without HFE expression (Figure 5c ). Furthermore, in okadaic acid-treated HFEexpressing cells, the level of TfR phosphorylation increased by at least five-fold when compared to the nonokadaic acid-treated, non-HFE-expressing cells ( Figure  5c ). These observations suggest that HFE is capable of inducing TfR phosphorylation and that TfR is rapidly dephosphorylated by cellular phosphatases.
Functional relationship between phosphorylation and endocytosis of TfR
If hyper-serine phosphorylation of TfR plays a direct role in inhibiting TfR endocytosis, it is reasonable to expect that the serine/threonine phosphatase inhibitor okadaic acid will prevent de-phosphorylation of TfR and will result in an inhibition of TfR endocytosis in a manner similar to HFE. Therefore, we compared the kinetics of cellular uptake of Tf under conditions where phosphorylated TfR was increased by treating cells with okadaic acid and/or by inducing HFE expression ( Figure 5 ). As shown in Figure 6 , the uptake of Tf in okadaic acid-treated cells was severely impaired, even though the level of surface expressed TfR remained the same under these experimental conditions (Table 1) . After okadaic acid treatment, the internalization rate constant, k int, was reduced from 0.13 to 0.018 min −1 ( Figure 6 , upper panel), which translates to a Tf internalization efficiency in okadaic acidtreated cells that was seven times slower than that in untreated cells. Under these experimental conditions, the k int for okadaic acid-treated cells and HFE-expressing cells was 0.018 and 0.07 min −1 , respectively. Thus, inhibition of TfR endocytosis by okadaic acid was four times greater than in cells expressing HFE. Because the amount of phosphorylated TfR increased proportionally with the time of HFE induction, the difference of TfR inhibition imposed by HFE or by okadaic acid can be interpreted as okadaic acid affected the phosphorylation state of almost all TfR molecules, while HFE affected only a fraction of TfR molecules that associated with HFE. Together with the findings that HFE induced accumulation of nonfunctional TfR at the cell surface and that HFE-induced TfR phosphorylation increased with the time of HFE induction, these results strongly suggest that the extent of inhibition of TfR function in LS15 cells is proportional to the increase in the levels of phosphorylated TfR that associates with HFE.
Discussion
The finding that the MHC-encoded HFE co-trafficks with the non-MHC-encoded molecule TfR to the cell surface, where they remain firmly associated, demonstrates that only HFE-associated TfR are functionally affected. This also implies that via MHC-encoded class I-like HFE, the immune system may play a role in the iron metabolic pathway. The binding of HFE might affect cofactors that associate with TfR, and ultimately the sorting and activity of the TfR. The observation that non-functional TfR is accumulated on the cell surface (Table 1) is consistent with the notion that HFE can retain TfR on the cell surface by inhibiting TfR endocytosis. Membrane receptors are sorted into coated pits by a cytoplasmic internalization signal that interacts with specific assembly or adaptor proteins. 27 The finding that HFE decreases the efficiency of Tf-bound TfR endocytosis suggests that HFE can prevent TfR from clustering in coated pits. It is possible that TfR-associated proteins that are displaced by HFE (Figure 5a ) are adaptor proteins and by preventing their interactions with the TfR internalization domain, HFE effectively inhibits the endocytosis of the Tf-TfR complexes via clathrin coated pits.
It is possible that cross talk between TfR and HFE, via physical association, may signal HFE to function as a TfR modulator. Indeed, HFE binding has been shown to 415 induce conformational changes in the TfR ectodomain, as revealed by a crystal structural analysis of the HFE-TfR complex. 28 The changes in the TfR ectodomain might interfere with the binding of the receptor to Tf or TfRassociated factors. Furthermore, as demonstrated in the present study, the binding of TfR to HFE may induce conformational changes in the cytoplasmic domain of HFE protein, which in turn may affect endocytosis or sorting of the TfR. The finding that the phosphorylation level of TfR inversely correlates with the level of intracellular Tf-iron, strongly suggests that inhibition of TfR endocytosis can be attributed to HFE-induced TfR phosphorylation. Different modes of phosphorylation of TfR seem to exert different effects on TfR function. As demonstrated in the present study, phosphorylation mediated by okadaic acid reduces Tf uptake at the steady state and decreases the rate of TfR endocytosis. 29 However, TfR endocytosis appears to be unaffected by phosphorylation mediated by protein kinase C or phorbol diester. 30, 31 These findings are consistent with the notion that depending on the phosphorylation-modulating agents employed, different residues on the TfR internalization domain can potentially be phosphorylated. In fact, it has been shown that only the serine residues are important for TfR endocytosis, implying a role for serine phosphorylation in TfR endocytosis. 20, [22] [23] [24] [25] [26] It is conceivable that phosphorylation of TfR at the serine residues might be favored by HFE-induced conformational changes in the TfR molecule. Indeed, our results show that HFE induces hyper-serine phosphorylation of TfR, which in turn affects TfR endocytosis. Consistent with the present study, treatment of the serine/threonine phosphatase inhibitor, okadaic acid, has been shown to result in a reduction on Tf binding to TfR, a decrease in the rate of intracellular Tf uptake, an increase in the numbers of surface expressed TfR, and an increase in the receptor phosphorylation levels. 32 In this regard, HFE seems to exert its effect on TfR in a manner almost identical to okadaic acid. Thus, it can be envisaged that HFE binding or okadaic acid can induce the same serine phosphorylation in the TfR molecule, and as a result, phosphorylated TfR fails to bind to the coated pits and remains on the cell surface.
In animals, defects in HFE function will lead to a progressive iron overload and eventually to hereditary hemochromatosis. 3 However, mutations in the MHC-encoded class I-like Hfe gene per se are insufficient to explain the physiopathology of the disease in human. It has been suggested that other genetic and environmental factors might contribute to the modulation of iron metabolism. [33] [34] [35] [36] In the more severe cases of iron overload, abnormally low numbers of lymphocytes, especially CD8 + T cells, remain a valuable indicator for disease prognosis. 37, 38 This, in conjunction with the finding that the class I-like HFE molecule is encoded in the MHC, strongly suggest that an interplay between iron metabolism and immune function must exist. Therefore, it is of considerable importance to define the molecular mechanisms that underlying the contribution of the immune system to iron homeostasis. In order to understand the relationship between the HFE-mediated and TfR-dependent iron metabolic machinery and immune function, it is necessary to understand the molecular mechanisms by which the MHC-encoded class I-like HFE expression is functionally regulated. Analysis of regulatory elements
Genes and Immunity present in the promoter region of the Hfe genes from different species has identified several conserved transcriptional regulatory elements. Among the most interesting are the NF-IL-6 binding site and the interferon response element. 39 NF-IL-6 is a C/EBP family member that upregulates the expression of IL-6 cytokine and is highly expressed in the intestine. 40 Interferon is a major cytokine that up-regulates the expression of almost all of the molecules involved in MHC antigen processing and presentation. 41 It can be envisaged that a direct and/or indirect induction of HFE expression by cytokines can potentially be the link between the iron metabolic pathway and the immune system. 5 Because HFE is expressed at different levels in different cell-and tissue-types, a question raises as to why macrophages and enterocytes do not have iron overload under conditions of HFE deficiencies. Recent reports on the identification and characterization of iron importers and exporters 3 provide some clues. It is possible that the plasma membrane-resident iron transporter ferroportin, which is highly expressed in macrophages and enterocytes, can effectively reduce intracellular iron levels by exporting iron out of these cells. Molecules such as ferritin, transferrin, TfR, HFE, ferroportin, and the iron importer Nramp2 are major players in the iron metabolic pathways. 5 Due to their cell type-specific expression and regulation by both the body's and cellular iron status, iron homeostasis is delicately maintained by these molecules. It is anticipated that future studies on the biochemical nature of HFE and its putative immune function in iron homeostasis will lead to therapeutic strategies to regulate iron uptake and iron concentrations in cellular compartments. These forms of intervention will have potential relevance in a variety of disease states, including hereditary hemochromatosis, and will provide methods for dealing with intracellular pathogenic organisms and possibly even some autoimmune disorders.
Materials and methods
DNA, antibodies, cells, and flow cytometry
Full-length Hfe cDNA in the pBI (Clontech, CA, USA) expression vector has been described. 6 The rabbit anti-HFE antiserum, HFE-C, was raised against a peptide corresponding to the 20 C-terminal amino acids of HFE (RKRQGSRGAMGHYVLAERE). 6 Anti-HFE monoclonal antibodies (mAbs) were raised by immunizing Balb/c mice with purified recombinant HFE-␤ 2 m heterodimers. Hybridomas were generated as described in Harlow and Lane. 42 Antibody specificity was determined by ELISA, flow cytometric analysis, immunofluorescence staining, Western blotting, and immunoprecipitation of HeLa and SC2 cells transiently expressing HFE or HLA-A2.1. The anti-HFE-C antiserum as well as the mAbs 34B4, 10G4, and 9G11 are specific for the HFE heavy chain, 6 whereas the mAb 8B6 cross-reacts with endogenous class I heavy chain. Epitope mapping by sandwich ELISA revealed that four mAbs (8B6, 9G11, 10G4, and 34B4) recognize different portions of the HFE polypeptide. Prior to the addition of the mAb 8B6, W6/32 (a mAb which recognizes MHC class I HLA-A, -B, and -C molecules) 43 was used for removal of endogenous class I molecules. Mouse anti-human TfR mAbs were purchased from Pharmingen (San Diego, CA, USA) and Caltag (Burlingame, CA, USA). Anti-phosphoserine, -phosphotyrosine, and -phosphothreonine antibodies were purchased from Sigma (St Louis, MO, USA). HeLa cells were transiently transfected by the calcium phosphate method as described 6 and were analyzed 3 days post-transfection. Stable transfectant cell lines were established by transfecting transactivatorexpressing HeLa cells 21 with the Hfe-pBI construct together with a plasmid conferring resistance against ouabain. 44 Unless otherwise stated, the LS15 transfectant was used in experiments 48 h after removing tetracycline. Transfected HeLa and LS15 cells were detached from petri dishes with 2 mM EDTA in PBS. Cell suspensions were washed with PBS containing 1% BSA at 4°C and incubated with biotinylated anti-HFE and FITC-conjugated anti-TfR mAbs. After washing, the cells were stained with PE-conjugated streptavidin (Pharmingen). For Tf binding experiments, HeLa cells transiently transfected with Hfe were incubated in serum-free DMEM for 1 h at 37°C. Cells were washed and incubated with 4 ug/ml of FITC-Tf (Molecular Probes, OR, USA) for 1 h at 37°C in DMEM containing 0.1% bovine serum albumin. After washing, staining for HFE and TfR was carried out as described. 6 Staining of intracytoplasmic molecules was performed using the Cytostain Kit (Pharmingen) according to manufacturer's instructions. Flow cytometric analysis was performed on a Becton Dickinson LYSIS II instrument.
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Metabolic radiolabeling, immunoprecipitation, PAGE, fluorography, and immunoblotting Metabolic radiolabeling, immunoprecipitations, SDS-PAGE, first-dimension nonequilibrium pH gradient gel electrophoresis (using Ampholines pH 3.5-10, Pharmacia), and fluorography were carried out as described. 45 To inhibit phosphatase activity, cells were incubated in chase medium containing 1 m okadaic acid (Calbiochem, CA, USA) for 30 min prior to lysis in 1% NP-40 lysis buffer, containing phosphatase inhibitors (1 m okadaic acid, 2 mm Na 3 VO 4 , 10 mm Na pyrophosphate, 0.4 mm EDTA, and 10 mm NaF). Following immunoprecipitation and SDS-PAGE, proteins were transferred to an Immobilon-P membrane (Millipore, MA, USA) and detected by ECL detection (Amersham, IL, USA). Membrane reprobing was carried out after washing in stripping solution according to manufacturer's instructions.
Transferrin binding, internalization, and iron uptake assays
To measure the kinetics of internalization and recycling of 125 I-Tf, we followed the procedure described by Jing et al. 46 Briefly, cells were incubated at 4°C for 1 h in prewarmed serum-free DMEM supplemented with 4 g/ml of 125 I-Tf (NEN, MA, USA) and then incubated for various times at 37°C in pre-warmed BSA-DMEM containing 50 g/ml of unlabeled diferric Tf. For the zero time point, ice-cold medium was added to these wells and then removed immediately. After an incubation at 37°C for the specific time, the medium was collected, cells were washed, and surface-bound Tf was removed by incubating these cells for 3 min twice with 0.5 ml of ice-cold 0.2 M acetic acid/0.5 M NaCl (pH 2.4). Cells were removed with 0.5 ml of 1 N NaOH, and radioactivity in the medium, acid wash, and NaOH pellet were counted in a gamma counter (Packard Instrument, CT, USA). The internalization rate constants were determined by using the IN/SUR plot 47 with some modifications, as described by McGraw and Maxfield. 18 Briefly, cells were incubated for 1 h at 37°C in serum-free DMEM containing 1.5 m okadaic acid. After washing, cells were incubated for various times at 37°C in BSA-DMEM supplemented with 4 g/ml 125 I-Tf. Surface-bound Tf was removed by acid wash. In control plates, the number of surface TfR was measured by incubating at 4°C for 90 min in BSA-PBS supplemented with 4 g/ml 125 I-Tf. Cells were solubilized in 1 N NaOH, and the amount of radioactivity was counted. A 200-fold excess of unlabeled diferric Tf was added to some wells to determine nonspecific binding, which was typically less than 10% of the total binding. All data was corrected for nonspecific binding. The rate constant of internalization was determined by the slope of the plot with the ratio of internalized Tf to steady-state surface Tf binding vs time. Human apo Tf (Calbiochem) was labeled with 59 Fe in the form of FeCl 3 , with a specific activity of 0.8-1 Ci/ug (Amersham), using nitrilotriacetic acid (NTA) as described by Hemmaplardh and Morgan, 48 at a ratio of 2 mol 59
Fe-NTA per mol of Tf. 48 Excess of radio-iron was removed by filtration through a PD-10 column (Pharmacia, Sweden). Iron uptake measurements were performed according to the protocol described by Jing et al. 46 Briefly, cells were incubated in BSA-DMEM containing 20 g/ml
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Fe-Tf at 37°C for 0, 1, 2, 3, and 4 h. After incubation, cells were removed in 0.5 ml of 1 N NaOH, and radioactivity was counted in a gamma counter. The relative levels of TfR expressed by the different cells were pre-determined for each experiment, as previously described.
